Lv2
110 积分 2022-10-24 加入
CORR Insights®: Are IDH1 R132 Mutations Associated With Poor Prognosis in Patients With Chondrosarcoma of the Bone?
1天前
已完结
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
1个月前
已完结
Cholangiocarcinoma Risk as Long‐term Outcome After Hepatic Resection in the Hepatolithiasis Patients
1个月前
已完结
Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation
1个月前
已完结
Cholangiocarcinoma — evolving concepts and therapeutic strategies
1个月前
已完结
Guillain–Barré syndrome
1个月前
已完结
[Chinese expert consensus on the whole-course standardized management of biliary tract cancer(2023)]
1个月前
已完结
[Expert consensus on conversion therapy of biliary tract cancer (2025)]
1个月前
已完结
The implications of IDH mutations for cancer development and therapy
1个月前
已完结
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
1个月前
已完结
皖公网安备34019202002308
